| Journal of Neurology Research, ISSN 1923-2845 print, 1923-2853 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Neurol Res and Elmer Press Inc |
| Journal website https://jnr.elmerpub.com |
Review
Volume 16, Number 4, December 2026, pages 238-249
Cardiac Emotional Memory: How Childhood Trauma May Contribute to Atrial Fibrillation and Youth Stroke Risk—A Neurocardiological Framework for Prevention
Figures


Tables
| Region | ≥ 1 ACE (%) | ≥ 4 ACEs (%) | Predominant ACEs categories | References |
|---|---|---|---|---|
| aWide range reflects substantial between-country variation and methodological heterogeneity across ACE survey instruments used in MENA studies. ACE prevalence figures for LMICs should be interpreted as likely underestimates due to (1) significant under-reporting in contexts with weaker child protection systems; (b) variation across ACE survey instruments—most LMIC studies use the WHO ACE-International Questionnaire (ACE-IQ) rather than the original 10-item Felitti framework; and (c) limited nationally representative data. Figures represent pooled or weighted estimates from the best available regional evidence. ACE: adverse childhood experience; LMIC: low- and middle-income country. | ||||
| High-income countries (reference) | Approximately 64% | Approximately 16% | Abuse, household dysfunction, neglect | [7] |
| Sub-Saharan Africa | Approximately 72–82% | Approximately 20–24% | Community and physical violence, orphanhood, sexual violence | [8] |
| South and Southeast Asia | Approximately 70–80% | Approximately 25–35% | Physical abuse, neglect, child labor, food insecurity | [9, 10] |
| Latin America | Approximately 65–75% | Approximately 20–30% | Community violence, household dysfunction, abuse | [7, 11] |
| Middle East and North Africa | Approximately 50–80%a | Approximately 20–30% | Conflict, displacement, physical abuse | [12] |
| Eastern Europe and Central Asia | Approximately 65–75% | Approximately 18–25% | Alcohol-related household dysfunction, physical abuse | [13] |
| Condition | AFib risk (HR/OR) | HRV changes in pediatric | Key developmental mechanism | References |
|---|---|---|---|---|
| aRisk estimate derived from PTSD-diagnosed cohorts; CPTSD-specific longitudinal cardiac data are not yet available. HR: hazard ratio; OR: odds ratio; RMSSD: root mean square of successive differences; HF: high-frequency HRV power; SDNN: standard deviation of NN intervals; LF/HF: low-to-high frequency ratio; ICNS: intrinsic cardiac nervous system; HPA: hypothalamic–pituitary–adrenal; IL-6: interleukin-6; CRP: C-reactive protein; CV: cardiovascular; CPTSD: complex post-traumatic stress disorder. | ||||
| High ACEs (≥ 4) | HR 1.18 (18% increase) | Decreased RMSSD; decreased HF power; blunted circadian HRV pattern | Early autonomic programming; epigenetic HPA reprogramming; accelerated sympathetic maturation | [1, 20] |
| CPTSD (childhood-onset) | HRa 1.13 (13% increase) | Decreased RMSSD, SDNN, HF; increased LF/HF ratio | Hyperarousal + DSO-related emotion dysregulation lead to sustained ICNS neuronal hypersensitivity; disrupted vagal maturation; executive functioning deficits impairing autonomic self-regulation | [15, 24, 27] |
| Depression (pediatric) | OR 1.25 (25% increase) | Decreased SDNN; decreased RMSSD; blunted nocturnal HRV rise | Chronic sympathetic dominance during neurodevelopment; increased IL-6, CRP in adolescents | [15] |
| Anxiety (child/adolescent) | HR 1.10 (10% increase) | Decreased HF-HRV; decreased baroreflex sensitivity | Heightened threat-appraisal circuitry leads to persistent vagal withdrawal | [15, 28] |
| Bipolar (early-onset) | OR up to 2.0 | Decreased overall HRV across mood phases | Mood instability + neuroinflammation impairing ICNS maturation | [15, 52] |
| ADHD | OR range: 1.8–2.0 (CV risk) | Decreased resting and task HRV; increased sympathetic reactivity | Dopaminergic–autonomic dysregulation; potential stimulant-mediated heart rate elevation | [16] |
| Therapeutic category | Intervention and target diagnosis | Effect on HRV in pediatric | Effect on psychiatric symptoms | Potential effect on long-term AFib risk | Feasibility in pediatric clinics | References |
|---|---|---|---|---|---|---|
| HRV: heart rate variability; RMSSD: root mean square of successive differences; HF: high-frequency HRV power; LF/HF: low-to-high frequency ratio; CPTSD: complex posttraumatic stress disorder; MDD: major depressive disorder; ADHD: attention-deficit/hyperactivity disorder; EMDR: eye movement desensitization and reprocessing; CPT: cognitive processing therapy; PE: prolonged exposure; AFib: atrial fibrillation; ICNS: intrinsic cardiac nervous system; MBSR: mindfulness-based stress reduction; niVNS: noninvasive vagus nerve stimulation; RCT: randomized controlled trial. | ||||||
| Psychotherapy | Trauma-focused EMDR, CPT, PE (pediatric-adapted); indicated for CPTSD, MDD, anxiety | Modest to moderate increase in RMSSD | Strong decrease in CPTSD/depression severity (d > 1.0) | Indirect benefit via decreasing chronic stress and inflammation | High: core pediatric clinic service | [44–46] |
| Behavioral therapy | HRV biofeedback and slow-paced breathing (about 6 breaths/min; gamified); targets autonomic dysregulation directly | Strong increase in RMSSD and HF power | Large decrease in anxiety and CPTSD (d range, 0.8–1.5) | Promising decrease in autonomic AFib triggers via vagal upregulation | Very high: highly engaging for children | [47, 48] |
| Educational therapy (EdTx) | Academic and cognitive skill remediation (reading, writing, numeracy); targets learning disabilities (dyslexia, dyscalculia). For CPTSD: targeted executive functioning remediation (working memory, cognitive flexibility, inhibitory control) as NPI for DSO-related neurocognitive deficits. Not a substitute for psychosocial interventions | No direct HRV effect; may indirectly support autonomic regulation through reduced academic stress and improved self-efficacy | Reduces behavioral problems and improves self-esteem in children with specific learning disabilities; indirect psychiatric benefit | Indirect AFib/stroke risk reduction in CPTSD via reduced cognitive-stress load and support of autonomic self-regulation; complementary to psychosocial NPIs across CPTSD, ADHD, and bipolar disorder | Very high: core service in pediatric therapy clinics; often already in place for ADHD and learning disability | [49] |
| Psychoeducation | Family and child psychoeducation on autonomic regulation, sleep hygiene, stress management; first-line for ADHD and bipolar disorder. | Indirect increase in HRV via behavior change | Increase in adherence and self-regulation; decrease in impulsivity and mood dysregulation | Indirect protection via lifestyle and medication optimization | Very high: scalable in pediatric clinics | [50, 51] |
| Mind–body/somatic approaches | Mindfulness (MBSR pediatric-adapted), yoga, pranayama breathing; suits anxiety, CPTSD, and depression | Increase in HF-HRV; decrease in LF/HF ratio | Increase in emotion regulation; decrease in rumination and hyperarousal | Moderate indirect benefit via autonomic flexibility | High: group or individual delivery | [53] |
| Physical/exercise therapy | Structured moderate aerobic exercise programs (pediatric); applicable across all diagnoses | Increase in vagal tone; increase in RMSSD | Decrease in depression and anxiety symptom scores | Decrease in systemic inflammation; decrease in atrial remodeling substrate; decrease in AFib burden | High: integrates with therapy and school physical education | [56] |
| Lifestyle modification | Sleep, dietary quality, screen time reduction, alcohol avoidance; underpins all other interventions | Significant increase in HRV across all domains | Moderate decrease in stress, depression, and anxiety | Up to 47% decrease in AFib risk in high-ACE pediatric | Moderate–high: requires family engagement | [1] |
| Emerging: vagal neuromodulation | Noninvasive auricular vagus nerve stimulation (niVNS); adjunct for refractory CPTSD/anxiety | Promising increase in HRV; direct vagal activation | Emerging benefit for mood and anxiety disorders | Potential direct ICNS calming; anti-arrhythmic properties | Moderate: requires specialist equipment | [57] |